Key market opportunities in the prefilled syringe fill finish sector include the rise in demand for self-medication, ...
Franklin Lakes-based BD (Becton, Dickinson and Company), a leading global medical technology company, on Tuesday announced plans to invest approximately $1.2 billion over a four-year period to expand ...
Key market opportunities in the fill finish manufacturing sector include rising demand for cell and gene therapies, expansion in personalized medicine production, and increased outsourcing to CMOs.
Fill Finish Manufacturing Market worth $28.14 billion by 2030 with 8.9% CAGR | MarketsandMarkets(TM)
The MarketWatch News Department was not involved in the creation of this content. DELRAY BEACH, Fla., Aug. 19, 2025 /PRNewswire/ -- The global Fill Finish Manufacturing Market, valued at US$16.85 ...
Dublin, Jan. 05, 2026 (GLOBE NEWSWIRE) -- The "Fill Finish Manufacturing Market - A Global and Regional Analysis: Focus on Product, End Users, and Region - Analysis and Forecast, 2025-2035" has been ...
Baxter Biopharma Solutions, the CDMO arm of healthcare giant Baxter, will shell out $100 million to expand its fill-finish manufacturing facility in Germany. The company plans to grow the footprint of ...
DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a global leader in sterile medication production and delivery, today announced a $50 million expansion of its sterile ...
FRANKLIN LAKES, N.J., Dec. 2, 2020 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced plans to invest approximately $1.2 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results